Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Eric B Harstad

2PUBLICATIONS
10CO-AUTHORS
PharmacogenomicsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|May 01, 2024
The Vedotin Antibody-Drug Conjugate Payload Drives Platform-Based Nonclinical Safety and Pharmacokinetic Profiles.

Haley D Neff-LaFord, Sarah A Carratt, Christopher Carosino

|Feb 08, 2022
Gut-Selective Design of Orally Administered Izencitinib (TD-1473) Limits Systemic Exposure and Effects of Janus Kinase Inhibition in Nonclinical Species.

Rhiannon N Hardwick, Patrick Brassil, Ilaria Badagnani

Pageof 1

Frequent Collaborators

1 joint publications

Rhiannon N Hardwick

1 joint publications

Haley D Neff-LaFord

1 joint publications

Sarah A Carratt

1 joint publications

Christopher Carosino

1 joint publications

Nancy Everds

1 joint publications

Kristen A Cardinal

1 joint publications

Steven Duniho

1 joint publications

Melissa M Schutten

1 joint publications

Christopher Frantz

1 joint publications

Christina Zuch de Zafra

Frequent Collaborators

1 joint publications

Rhiannon N Hardwick

1 joint publications

Haley D Neff-LaFord

1 joint publications

Sarah A Carratt

1 joint publications

Christopher Carosino

Top Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

992
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.2K
See more related videos

Top Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on : May 09, 2025

992
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on : Apr 07, 2023

1.2K
See more related videos